BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17223851)

  • 1. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
    Park D; Kåresen R; Axcrona U; Noren T; Sauer T
    APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer.
    Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO
    J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
    J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Jeschke U; Mylonas I; Kuhn C; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2007; 27(4A):1969-74. PubMed ID: 17649807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
    Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
    Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of E-cadherin and catenins in invasive mammary carcinomas.
    Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W
    Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between the expression of E-cadherin-catenins and alpha-, beta-, gamma-catenin and the metastasis and prognosis of breast cancer].
    Zou W; Hu CH; Zhou JP
    Hunan Yi Ke Da Xue Xue Bao; 2002 Dec; 27(6):499-502. PubMed ID: 12658921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
    Liu J; Ikeguchi M; Nakamura S; Kaibara N
    J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast.
    Gillett CE; Miles DW; Ryder K; Skilton D; Liebman RD; Springall RJ; Barnes DM; Hanby AM
    J Pathol; 2001 Apr; 193(4):433-41. PubMed ID: 11276001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
    Lim SC; Lee MS
    Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids.
    Pelosi G; Scarpa A; Puppa G; Veronesi G; Spaggiari L; Pasini F; Maisonneuve P; Iannucci A; Arrigoni G; Viale G
    Cancer; 2005 Mar; 103(6):1154-64. PubMed ID: 15712207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J; Benito N; Pizarro A; Suárez A; Espada J; Cano A; Gamallo C
    Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E-cadherin expression in primary carcinomas of the breast and its distant metastases.
    Kowalski PJ; Rubin MA; Kleer CG
    Breast Cancer Res; 2003; 5(6):R217-22. PubMed ID: 14580257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between the expression of adhesion molecules in primary esophageal squamous cell carcinoma and metastatic lymph nodes.
    Takayama N; Arima S; Haraoka S; Kotho T; Futami K; Iwashita A
    Anticancer Res; 2003; 23(6a):4435-42. PubMed ID: 14666731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
    Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma.
    Ramasami S; Kerr KM; Chapman AD; King G; Cockburn JS; Jeffrey RR
    J Pathol; 2000 Dec; 192(4):427-32. PubMed ID: 11113858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer.
    Pellikainen J; Kataja V; Ropponen K; Kellokoski J; Pietiläinen T; Böhm J; Eskelinen M; Kosma VM
    Clin Cancer Res; 2002 Nov; 8(11):3487-95. PubMed ID: 12429639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.